title: Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants.
abstract: We evaluated growth indices in two cohorts of Malawian infants exposed to tenofovir, lamivudine and efavirenz in utero and during 12 months of breastfeeding, and to stavudine/zidovudine, lamivudine and nevirapine in utero and during 6 months of breastfeeding. Growth indices were similar in the two cohorts at one and 6 months but were significantly better in the first group at 12 months, suggesting no negative effect of tenofovir and a significant benefit of extended breastfeeding.
authors.affiliation: aDepartment of Biomedicine and Prevention, University of Rome Tor VergatabDepartment of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, ItalycDREAM Program, Community of S.Egidio, Blantyre, MalawidLUMSA University, Rome, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Liotta
authors.forename: Marco
authors.initials: M
authors.lastname: Floridia
authors.forename: Mauro
authors.initials: M
authors.lastname: Andreotti
authors.forename: Haswell
authors.initials: H
authors.lastname: Jere
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Sagno
authors.forename: Maria C
authors.initials: MC
authors.lastname: Marazzi
authors.forename: Ersilia
authors.initials: E
authors.lastname: Buonomo
authors.forename: Paola
authors.initials: P
authors.lastname: Scarcella
authors.forename: Sandro
authors.initials: S
authors.lastname: Mancinelli
authors.forename: Stefano
authors.initials: S
authors.lastname: Vella
authors.forename: Marina
authors.initials: M
authors.lastname: Giuliano
authors.forename: Leonardo
authors.initials: L
authors.lastname: Palombi
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001942:Breast Feeding; D002657:Child Development; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008295:Malawi; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D000068698:Tenofovir / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir